Related Experiment Video
Updated: Jun 21, 2026
06:23
The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
Is dementia preventable?
1Tel-Aviv University Medical School, Ramat-Aviv, Tel-Aviv, Israel. amoskor@post.tau.ac.il
Dialogues in Clinical Neuroscience
|July 10, 2009
Summary
Dementia poses a growing public health challenge with limited treatment options. Identifying and addressing risk factors like hypertension and smoking may help prevent dementia, though proving efficacy is difficult.
Area of Science:
- Public Health
- Epidemiology
- Neurology
Background:
- Dementia is a significant and escalating global health concern.
- Current treatments offer minimal and short-term benefits, with no cure found.
- Epidemiological research has identified key risk factors for dementia, including Alzheimer's and vascular dementia.
Purpose of the Study:
- To highlight the public health significance of dementia.
- To discuss the potential for intervention based on identified risk factors.
- To explore the link between modifiable risk factors and dementia prevention.
Main Methods:
- Review of epidemiological studies on dementia risk factors.
- Analysis of non-genetic risk factors such as hypertension, hyperlipidemia, smoking, and obesity.
- Discussion of the implications for public health interventions.
Main Results:
- Dementia is a major public health issue with increasing prevalence.
- Established risk factors include hypertension, hyperlipidemia, smoking, and obesity.
- These factors are also linked to cardiovascular disease.
Conclusions:
- Modifiable risk factors present an opportunity for dementia prevention strategies.
- Addressing factors like hypertension and smoking may reduce dementia incidence.
- Further research is needed to definitively prove the efficacy of these preventive measures for dementia.
Related Concept Videos
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...